Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Monoclonal Gammopathy of Undetermined Significance × Dalteparin × Clear all

Sponsor

Conditions

Venous Thromboembolism 7 Pulmonary Embolism 5 Venous Thrombosis 4 Neoplasms 4 Neoplasm Metastasis 2 Thrombosis 1 Sarcoma 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Mesenteric Ischemia 1 Lymphoma 1 Intracranial Thrombosis 1 Fractures, Spontaneous 1 Femoral Fractures 1 Bone Neoplasms 1 Acute Deep Vein Thrombosis 1

Interventions

Darbepoetin alfa 2 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 Whole-Body Irradiation 1 Urination 1 Therapeutics 1 Sucrose 1 Rituximab 1 Phenytoin 1 Peripheral Blood Stem Cell Transplantation 1 Oxycodone 1 Mycophenolic Acid 1 Morphine 1 Methotrexate 1 Methadone 1 Metformin 1 KW-2478 1 Hsp90 inhibitor KU757 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Fentanyl 1 Fatty Acids, Omega-3 1 Epoetin Alfa 1 Early Intervention, Educational 1 Cyclosporine 1 Celecoxib 1 Busulfan 1 Bortezomib 1 Asian ginseng 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡